DNA X SONM 深 沪
已收盘 07-02 16:00:00 美东时间
3.75
-1.510
-28.71%
华盛通- 最 高5.17
- 今 开5.15
- 成交量 18.91万股
- 最 低 3.1801
- 昨 收 5.26
- 总市值 558.10万
- 52周最高 16.974
- 市盈率 静 --
- 换手率 12.71%
- 52周最低 2.5211
- 委 比 -73.97%
- 总股本 148.83万
- 历史最高 32864.40
- 量 比 8.30
- 振 幅 37.83%
- 历史最低 2.62
- 每 手 1
- 风险率 3.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sonim Technologies Strengthens Capital Structure With Preferred Financing
Sonim Technologies ( ($SONM) ) has provided an announcement. On June 29, 2026, ...
07-02 21:28
DNA X Announces $8.1M Private Placement Of 1.35M Series B Preferred Shares At $6.00/Share, Including $5M Cash And $3.1M Debt Cancellation
On June 29, 2026, DNA X, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with DNA Holdings Venture, Inc. ("DNA Holdings"), a holder of more than 5% of the Company’s outstanding capital stock and an entity associated with Scott Walker, a member of the Comp...
07-02 20:59
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Gainers Astrotech (NASDAQ:ASTC) stock rose 43.4% to $50.76 during Tuesday's re...
06-03 01:06
Sonim Technologies Faces Nasdaq Delisting After New Financing
Sonim Technologies ( ($SONM) ) has shared an update. On May 20, 2026, DNA X, In...
05-28 05:43
DNA X shares are trading lower after the company reported worse-than-expected Q1 EPS results.
DNA X shares are trading lower after the company reported worse-than-expected Q...
05-21 23:34
Sonim Technologies Q1 EPS $5.01 Misses $5.04 Estimate
Sonim Technologies (NASDAQ:SONM) reported quarterly earnings of $5.01 per share which missed the analyst consensus estimate of $5.04 by 0.6 percent. This is a 255.32 percent increase over earnings of $1.41 per share from
05-21 05:07
DNA X GAAP EPS of -$11.00
DNA X, Inc press release (SONM): FY GAAP EPS of -$11.00. "Cash Position: We ended the year with $1.3 million in cash from continuing operations. This cash plus cash proceeds from the asset sale will b...
04-15 15:41
DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million
DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million DNA X posted 2025 net loss of $20.7 million. Continuing-operations net loss widened to $8 million from $2.9 million, while revenue showed no revenue. General and administrative expense climbed to $5.4 million from $3.1
04-15 09:35
DNA X’s NEXA teams with AT&T to offer Sonim XP Pro Thermal on 5G, FirstNet
DNA X’s NEXA teams with AT&T to offer Sonim XP Pro Thermal on 5G, FirstNet DNA X unit NEXA formed partnership with AT&T to offer Sonim XP Pro Thermal 5G rugged smartphone exclusively on AT&T commercial 5G network. Deal includes availability for public safety users on FirstNet, AT&T’s network for fir
04-07 18:17
DNA X, Inc. delays 2025 annual filing
Sonim Technologies ( ($SONM) ) has released a notification of late filing. DNA ...
04-02 02:25
